22nd Century Group Inc (USD)
XXII
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range0.58 | 0.58
52-Wk Range- | -
Last Close0.58
Mkt Cap (m)81.19
Dividend yield-
ISINUS90137F1030
Volume185,204.00
Exchange VenueASE

Company Profile

22nd Century Group Inc is a plant biotechnology company. It is focused on technology that allow to increase or decrease the level of nicotine and other nicotinic alkaloids in tobacco plants and levels of cannabinoids in cannabis plants.

Key Information
Price/Earning-
Price/Book1.51
Price/Sales2.86
P/CF-
Rev Growth (3 year avg)28.13
EPS Growth (3 year avg)-
Operating Margin % -86.81
Net Margin %-102.81
Return on Equity-39.84
Debt/Equity0.02

Documents

Prospectus
en 23/12/2019
Annual Report
en 31/12/2019

Please refer to the below issuer website for further documents.

https://www.xxiicentury.com

Financials

Income Statement
USD201420152016201720182019
Revenue (m)0.538.5212.2816.6026.4325.83
Operating Income (m)-11.74-12.04-11.39-13.30-24.02-22.42
Net Income (m)-15.60-11.03-11.58-13.03-7.97-26.56
Basic EPS-0.26-0.16-0.15-0.13-0.06-0.21
Avg. Diluted Shares Outstanding (m)59.9968.1479.84101.16124.30125.88
Balance Sheet
USD201420152016201720182019
Current Assets (m)10.717.2316.8067.6261.2042.74
Non Current Assets (m)11.2511.1410.8412.1216.1026.21
Total Assets (m)21.9518.3727.6479.7477.3068.95
Current Liabilities (m)2.673.243.254.315.175.78
Total Liabilities (m)------
Total Equity (m)15.2211.7324.3375.4371.2862.05
Cash Flows
USD201420152016201720182019
Operating Cash Flows (m)-6.58-7.32-9.89-12.07-17.84-14.59
Capital Expenditure (m)-2.39-0.45-0.55-1.61-1.11-1.09
Figures are quoted in USD unless stated otherwise
0.00 (-0.41%)
$
0.58
Last Price